Anebulo Pharmaceuticals (ANEB) Stock Chart & Stock Price History $1.26 -0.16 (-10.95%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.28 +0.02 (+1.59%) As of 02/21/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Anebulo Pharmaceuticals Stock Price Performance 5 Day Performance-5.26%1 Month Performance-21.25%3 Month Performance-13.70%6 Month Performance-35.38%Year-To-Date Performance-25.00%1 Year Performance-56.55% Receive ANEB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ANEB Stock Chart for Saturday, February, 22, 2025 ANEB Chart by TradingView Anebulo Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$1.42$1.26-10.95%$1.41$1.2512,357 shs$32.67 million02/20/2025$1.53$1.42-7.52%$1.53$1.3711,195 shs$36.69 million02/19/2025$1.46$1.53+4.79%$1.53$1.3622,366 shs$39.67 million02/18/2025$1.33$1.46+9.77%$1.56$1.334,922 shs$37.86 million02/17/2025$1.33$1.33$1.39$1.331,654 shs$34.49 million02/14/2025$1.33$1.33$1.39$1.331,654 shs$34.49 million02/13/2025$1.44$1.33-7.64%$1.48$1.3317,653 shs$34.49 million02/12/2025$1.47$1.44-2.04%$1.48$1.412,110 shs$37.34 million02/11/2025$1.47$1.47$1.48$1.454,759 shs$38.12 million02/10/2025$1.53$1.47-3.92%$1.61$1.455,074 shs$38.12 million Get the Latest News and Ratings for ANEB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$1.57$1.53-2.55%$1.57$1.452,741 shs$39.67 million02/06/2025$1.57$1.57$1.72$1.5011,380 shs$40.71 million02/05/2025$1.53$1.57+2.61%$1.57$1.454,863 shs$40.71 million02/04/2025$1.60$1.53-4.38%$1.53$1.471,859 shs$39.67 million02/03/2025$1.56$1.60+2.89%$1.75$1.4293,116 shs$41.49 million01/31/2025$1.59$1.56-2.20%$1.59$1.46490 shs$40.33 million01/30/2025$1.56$1.59+1.99%$1.70$1.495,288 shs$41.23 million01/29/2025$1.48$1.56+5.05%$1.54$1.54730 shs$40.43 million01/28/2025$1.50$1.48-1.07%$1.54$1.501,502 shs$38.48 million01/27/2025$1.54$1.50-2.59%$1.59$1.3929,338 shs$38.90 million01/24/2025$1.56$1.54-1.28%$1.59$1.4518,618 shs$39.93 million01/23/2025$1.60$1.56-2.50%$1.58$1.4515,203 shs$40.45 million01/22/2025$1.67$1.60-4.19%$1.66$1.536,273 shs$41.49 million01/21/2025$1.59$1.67+5.03%$1.67$1.5220,635 shs$43.30 million Related Companies BioXcel Therapeutics Stock Price Chart Nkarta Stock Price Chart Silence Therapeutics Stock Price Chart Zentalis Pharmaceuticals Stock Price Chart Fate Therapeutics Stock Price Chart ADC Therapeutics Stock Price Chart Sagimet Biosciences Stock Price Chart Solid Biosciences Stock Price Chart Puma Biotechnology Stock Price Chart Biomea Fusion Stock Price Chart Receive ANEB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANEB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anebulo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
